Información:
Error:
ID
34413
Descripción
Role of Vitamin D in Reducing the Relapse Rate in Patients With Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT01753375
Link
https://clinicaltrials.gov/show/NCT01753375
Palabras clave
Versiones (1)
- 17/1/19 17/1/19 -
Titular de derechos de autor
GSK group of companies
Subido en
17 de enero de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Multiple Sclerosis NCT01753375
Eligibility Multiple Sclerosis NCT01753375
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Sclerosis NCT01753375
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
ID.1
Item
age between 18-55 years
boolean
ID.2
Item
confirmed multiple sclerosis diagnosis according to mcdonald criteria
boolean
ID.3
Item
stable neurological functioning for at least one month prior to study entry
boolean
ID.4
Item
expanded disability scale score (edss) less than <_4.0
boolean
ID.5
Item
must have had one clinical attack in past two years and at least one new silent t2 or gadolinium-enhancing lesion on mri within the past one year.
boolean
ID.6
Item
willing to participate for the entire 52-week period
boolean
ID.7
Item
pregnant or nursing.
boolean
ID.8
Item
connective tissue disease (sle, sjogren's disease)
boolean
ID.9
Item
endocrine disease (hyperthyroidism, hyperparathyroidism)
boolean
ID.10
Item
any medical condition predisposing to hypercalcaemia, nephrolithiasis or renal insufficiency
boolean